Abstract:Purpose: To determine the efficacy and postoperative complications of complex deep lamellar endothelial keratoplasty (DLEK) when used for the management of complex bullous keratopathy with severe vision loss. Methods: Twelve consecutive eves with severe bullous keratopathy and other associated intraocular abnormalities underwent complex DLE-K which was combined with other intraocular Surgeries such as vitrectomy intraocular lens removal, and secondary intraocular lens implantation. An air bubble was used in 9 eyes and all air and C3F8 gas bubble in 3 eyes for tissue support. Prospective data of best spectacle-corrected visual acuity, corneal astigmatism, and curvature were collected oil all 12 eyes preoperatively and at 6, 9, and 12 months postoperatively. Average donor endothelial cell density was recorded preoperatively and at 9 months postoperatively. Results: Preoperatively, severe visual loss was recorded at hand motions (n = 3). count fingers (n = 7). and 20/400 (n = 2), Best spectacle-corrected visual acuity improved in 83% of eyes with vision of 20/67 or better in 42% (5/12) and 20/100 or better in 66% (8/12) of eyes at 12 months postoperatively. Vision was not improved in three eves due to coexistent retinal disease. Four aphakic eyes underwent secondary intraocular lens implantation later at 4-6 months after DLEK. and best spectacle-corrected Visual acuity was increased from Count fingers to 20/200 or better. At 12 months postoperatively. average corneal astigmatism and curvature were 2.3 +/- 0.5 diopters and 44.0 +/- 0.9 diopters, respectively. Average central corneal thickness at 12 months postoperatively (541.3 +/- 26.7 mu m) was significantly thinner than that before surgery (673.8 +/- 77.5 mu m, P < 0.01). Preoperative average donor endothelial cell density was 2685.1 +/- 193.9 cells/mm(2). At 9 months postoperatively, average endothelial cell density was 1920.1 +/- 94.0 cells/mm(2) (27.3% of endothelial cell loss) in eyes with primary Surgery and 1866.3 +/- 92.8 cells/mm(2) (33.9% of endothelial cell loss) in eyes with secondary surgery. Postoperative complications usually occurred within 3 months Of Surgery. After surgery, 3 eyes showed narrow gaps between the border of the graft and the host. Epithelial bullae ill these areas recurred in 2 eyes but disappeared within 3 months. There was one graft dislocation in this series, no pupillary block cases, and no primary graft failures. Conclusions: In cases of complex bullous keratopathy with severe vision loss, DLEK combined with other intraocular surgeries is a feasible and effective procedure to significantly improve visual acuity to a functional level it) most patients. DLEK call be Used Successfully in eyes with aphakia and other anterior segment abnormalities without a high risk of graft dislocation or failure. Mild postoperative complications usually occurred early after DLEK and did not affect visual outcomes and graft survival if managed appropriately.

Preliminary Clinical Study of Non-Descemet Stripping Endothelial Keratoplasty for Bullous Keratopathy

Observation of femtosecond laser-assisted Descemet's stripping endothelial keratoplasty for bullous keratopathy

[Clinical Study of Descemet Membrane Stripping with Automated Endothelium Keratoplasty].

Modified endothelial keratoplasty for bulbous keratopathy

[Experimental Research of Small-Incision Descemet's Stripping Endothelial Keratoplasty].

Initial Clinical Results of Small Incision Deep Lamellar Endothelial Keratoplasty

Surgical Management of Bullous Keratopathy

[Non-Descemet Stripping Endothelial Keratoplasty for Treating Iridocorneal Endothelial Syndrome in Phakic Eyes].

Deep lamellar endothelial keratoplasty for bullous keratopathy]

Current progress on etiology and clinical treatment of bullous keratopathy

Preliminary clinical study of sutureless, small-incision deep lamellar endothelial keratoplasty surgery

Accelerated Corneal Collagen Cross-Linking in Eyes with Incurable Bullous Keratopathy

Research on Descemet's stripping with endothelial keratoplasty

Use of Paediatric Donor Tissue in Descemet Stripping Endothelial Keratoplasty

Complex deep lamellar endothelial keratoplasty for complex bullous keratopathy with severe vision loss.

Comprehensive combined analysis of physician-initiated phase II and III clinical trials on a cultured human corneal endothelial cell product for treating bullous keratopathy

[The Effect of Descemet-Stripping Automated Endothelial Keratoplasty Combined with Phacoemulsification Cataract Surgery or Lens Exchange].

[Descemet's Membrane Endothelial Keratoplasty for Treatment of Patients with Corneal Endothelial Decompensation].

Femtosecond Laser-Assisted Descemet’s Stripping Endothelial Keratoplasty: a Prospective Study of 6-Month Visual Outcomes, Corneal Thickness and Endothelial Cell Loss

Clinical Outcomes of Descemet Membrane Endothelial Keratoplasty Using Eye Bank-Prepared Tissues.

Descemet Membrane Stripping Endothelial Keratoplasty with Neonate Donors in Two Cases